About Semarion
Semarion: Revolutionizing Cell Screening with Unique Assaying Microcarrier Platform
Semarion is a Cambridge-based technology company that is changing the way cell screening is done. With its unique assaying microcarrier platform, Semarion has revolutionized the field of cell screening and has become a leading player in this space.
The company was founded by a team of experienced scientists and engineers who saw an opportunity to improve the accuracy and efficiency of cell screening. They developed a proprietary microcarrier platform that allows for high-throughput, multiplexed assays on live cells.
Semarion's microcarriers are designed to mimic the extracellular matrix (ECM) found in living tissues. This allows for more accurate and physiologically relevant assays, which can lead to better drug discovery and development.
One of the key advantages of Semarion's technology is its ability to perform multiplexed assays on live cells. This means that multiple tests can be run simultaneously on the same sample, which saves time and resources while also providing more comprehensive data.
Another advantage of Semarion's technology is its scalability. The microcarriers can be produced in large quantities, making it possible to perform high-throughput screening on thousands or even millions of samples at once.
Semarion's technology has already been adopted by several major pharmaceutical companies, as well as academic research institutions around the world. Its applications include drug discovery, toxicity testing, disease modeling, and personalized medicine.
In addition to its innovative technology platform, Semarion also offers a range of services to support its customers' research needs. These include assay development and optimization, data analysis and interpretation, as well as custom assay design for specific research questions.
Overall, Semarion represents an exciting new frontier in cell screening technology. Its unique assaying microcarrier platform offers unparalleled accuracy and efficiency in drug discovery research while also providing valuable insights into disease mechanisms at the cellular level. With its growing list of customers and partners, Semarion is poised to become a major player in the field of cell screening and drug discovery.